Follows children using medical cannabis for cancer, epilepsy or neurodevelopmental disorders
Observes 500 children aged 3 to 17 who have medical cannabis authorizations.
Plain-language title generated from the registry record
Registry title: Real World Evidence on the Use of Medical Cannabis in Pediatrics
Key facts
- Where
- Winnipeg, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 17 years old?
Source: NCT05863910, who can take part
Where in Canada
- U ManitobaWinnipeg, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Manitoba
- Trial code
- NCT05863910
- Record updated
- 30 November 2023
- Original description
CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.Read full original descriptionShow less
Real World Evidence on the Use of Medical Cannabis in Pediatrics: A Prospective Observational Study
CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.
Inclusion: 3 to 17 years; have a medical document provided by a prescribing health care practitioner (i.e. physician, nurse practitioner, etc.) for the use of medical cannabis; medical cannabis is authorized for pain, sleep, mood, behaviour, seizures, cancer or cancer-treatment related symptom management; ability to respond to electronic questionnaires in English.
Exclusion: individuals using cannabis for medical purposes without a medical cannabis authorization from a health care provider; those only using cannabis recreationally.